Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)
HKD 1.3
(-2.99%)
HKD 1.3
(-2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -364.19 Million | -292.41 Million | -147.49 Million | 78.82 Million | -113.02 Million | -79.89 Million |
| Net Income | -359.11 Million | -371.86 Million | -301.18 Million | -1.51 Billion | -425.81 Million | -155.93 Million |
| Depreciation & Amortization | 25.08 Million | 13.79 Million | 10.79 Million | 8.38 Million | 13.18 Million | 8.51 Million |
| Deferred income taxes | - | - | 33.25 Million | 1.72 Billion | 231.93 Million | 49.23 Million |
| Stock-based compensation | 14.85 Million | 16.99 Million | 19.44 Million | 19.65 Million | 68.64 Million | 11.72 Million |
| Change in working capital | -13.15 Million | 131.91 Million | 108.4 Million | -160.64 Million | 2.98 Million | 4.98 Million |
| Other non-cash items | -38.75 Million | -83.26 Million | -18.19 Million | -1.64 Million | -3.95 Million | 1.59 Million |
| Investing Cash Flow | -48 Million | -686.32 Million | 161.66 Million | -215.56 Million | -273 Thousand | 14.58 Million |
| Investments in PPE | -38.66 Million | -16.5 Million | -11.13 Million | -10.95 Million | -3.34 Million | -16.08 Million |
| Acquisitions | - | - | -470 Thousand | -41 Thousand | 2.82 Million | 1.38 Million |
| Investment purchases | -5.53 Million | -667.47 Million | -16.14 Million | -194 Million | -26 Million | -150.61 Million |
| Sales/Maturities of investments | 808.7 Million | 1.99 Million | 2.76 Million | 264.16 Million | 227.8 Million | 204.84 Million |
| Other Investing Activities | 10.75 Million | -4.34 Million | 186.65 Million | -274.73 Million | -201.56 Million | -24.95 Million |
| Financing Cash Flow | 246.27 Million | -9.85 Million | 109.05 Million | 1.27 Billion | 929 Thousand | 356.82 Million |
| Debt repayment | -73.61 Million | -7.59 Million | -11.36 Million | -8.45 Million | -692 Thousand | - |
| Dividends payments | - | - | - | - | - | -17.04 Million |
| Common Stock Repurchased | -5.68 Million | - | -11.89 Million | - | - | - |
| Common Stock Issuance | 139.13 Million | - | 132.83 Million | 1.1 Billion | - | - |
| Other Financing Activities | 60.61 Million | -2.25 Million | 10.85 Million | 180.32 Million | 1.62 Million | 373.87 Million |
| Accounts receivables | 10.37 Million | 79.07 Million | 89.03 Million | -187.93 Million | -1.72 Million | -6.59 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.75 Million | 52.84 Million | 19.36 Million | 27.29 Million | 4.7 Million | 1.48 Million |
| Cash at beginning of period | 624.37 Million | 1.52 Billion | 1.43 Billion | 314.33 Million | 420.83 Million | 126.86 Million |
| Cash at end of period | 469.15 Million | 624.37 Million | 1.52 Billion | 1.43 Billion | 314.33 Million | 420.83 Million |
| Capital Expenditure | -38.66 Million | -16.5 Million | -11.13 Million | -10.95 Million | -3.34 Million | -16.08 Million |
| Effect of forex changes on cash | 10.7 Million | 85.76 Million | -26.44 Million | -22.56 Million | 5.87 Million | 2.45 Million |
| Net cash flow / Change in cash | -155.22 Million | -902.82 Million | 96.78 Million | 1.11 Billion | -106.49 Million | 293.96 Million |
| Free Cash Flow | -402.85 Million | -308.92 Million | -158.62 Million | 67.86 Million | -116.36 Million | -95.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -84.52 Million | -84.52 Million | -96.41 Million | -359.11 Million | -96.41 Million | -83.14 Million |
| Depreciation & Amortization | 6.87 Million | 6.87 Million | 7.56 Million | 25.08 Million | 7.56 Million | 4.97 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.7 Million | 2.7 Million | 3.77 Million | 14.85 Million | 3.77 Million | 3.64 Million |
| Change in working capital | - | - | 1.31 Million | -13.15 Million | 1.31 Million | - |
| Other non-cash items | -15.26 Million | -15.26 Million | 11.54 Million | -38.75 Million | 11.54 Million | -35.36 Million |
| Investing Cash Flow | 21.84 Million | 21.84 Million | -109.3 Million | -48 Million | -109.3 Million | 85.3 Million |
| Investments in PPE | -2.73 Million | -2.73 Million | -1.72 Million | -38.66 Million | -1.72 Million | -17.18 Million |
| Acquisitions | - | - | - | - | - | 1.62 Million |
| Investment purchases | - | - | - | -5.53 Million | - | -329.13 Million |
| Sales/Maturities of investments | - | - | - | 808.7 Million | - | 545.64 Million |
| Other Investing Activities | 24.58 Million | 24.58 Million | -107.57 Million | 10.75 Million | -107.57 Million | 102.49 Million |
| Financing Cash Flow | 12.88 Million | 12.88 Million | 28.47 Million | 246.27 Million | 28.47 Million | 94.66 Million |
| Debt repayment | - | - | - | -73.61 Million | - | -67.85 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.64 Million | -1.64 Million | -2.84 Million | -5.68 Million | -2.84 Million | - |
| Common Stock Issuance | - | - | - | 139.13 Million | - | 157.35 Million |
| Other Financing Activities | 14.52 Million | 14.52 Million | 31.31 Million | 60.61 Million | 31.31 Million | 94.66 Million |
| Accounts receivables | - | - | 5.18 Million | 10.37 Million | 5.18 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -3.87 Million | -7.75 Million | -3.87 Million | - |
| Cash at beginning of period | - | - | - | 624.37 Million | - | 1.45 Billion |
| Cash at end of period | -53.67 Million | -53.67 Million | -157.23 Million | 469.15 Million | -157.23 Million | 1.4 Billion |
| Capital Expenditure | -2.73 Million | -2.73 Million | -1.72 Million | -38.66 Million | -1.72 Million | -17.18 Million |
| Effect of forex changes on cash | 1.81 Million | 1.81 Million | -4.18 Million | 10.7 Million | -4.18 Million | 9.53 Million |
| Net cash flow / Change in cash | -53.67 Million | -53.67 Million | -157.23 Million | -155.22 Million | -157.23 Million | -57.87 Million |
| Free Cash Flow | -92.95 Million | -92.95 Million | -73.94 Million | -402.85 Million | -73.94 Million | -127.06 Million |
PEN
NCPLW
BP
3265
002193
2165